1.Rasmussen SA, Eisen JL: The epidemiology and differential diagnosis of obsessive-compulsive disorder. J Clin Psychiatry 1992; 53(suppl):4–10
2.Insel TR: Toward a neuroanatomy of obsessive-compulsive disorder. Arch Gen Psychiatry 1992; 49:739–744
3.Rapoport JL, Wise SP: Obsessive-compulsive disorder: evidence for basal ganglia dysfunction. Psychopharmacol Bull 1988; 24:380–384
4.Alexander GE, DeLong MR, Strick PL: Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986; 9:357–381
5.Pujol J, Soriano-Mas C, Alonso P, Cardoner N, Menchon JM, Deus J, Vallejo J: Mapping structural brain alterations in obsessive-compulsive disorder. Arch Gen Psychiatry 2004; 61:720–730
6.Szeszko PR, Robinson D, Alvir JM, Bilder RM, Lencz T, Ashtari M, Wu H, Bogerts B: Orbital frontal and amygdala volume reductions in obsessive-compulsive disorder. Arch Gen Psychiatry 1999; 56:913–919
7.Szeszko PR, MacMillan S, McMeniman M, Chen S, Baribault K, Lim KO, Ivey J, Rose M, Banerjee SP, Bhandari R, Moore GJ, Rosenberg DR: Brain structural abnormalities in psychotropic drug-naive pediatric patients with obsessive-compulsive disorder. Am J Psychiatry 2004; 161:1049–1056
8.Rosenberg DR, Keshavan MS: AE Bennett Research Award: toward a neurodevelopmental model of obsessive-compulsive disorder. Biol Psychiatry 1998; 43:623–640
9.Valente AA Jr, Miguel EC, Castro CC, Amaro E Jr, Duran FL, Buchpiguel CA, Chitnis X, McGuire PK, Busatto GF: Regional gray matter abnormalities in obsessive-compulsive disorder: a voxel-based morphometry study. Biol Psychiatry 2005; 58:479–487
10.Kim JJ, Lee MC, Kim J, Kim IY, Kim SI, Han MH, Chang KH, Kwon JS: Gray matter abnormalities in obsessive-compulsive disorder: statistical parametric mapping of segmented magnetic resonance images. Br J Psychiatry 2001; 179:330–334
11.Szeszko PR, MacMillan S, McMeniman M, Lorch E, Madden R, Ivey J, Banerjee SP, Moore GJ, Rosenberg DR: Amygdala volume reductions in pediatric patients with obsessive-compulsive disorder treated with paroxetine: preliminary findings. Neuropsychopharmacology 2004; 29:826–832
12.Whiteside SP, Port JD, Abramowitz JS: Meta-analysis of functional neuroimaging in obsessive-compulsive disorder. Psychiatry Res 2004; 132:69–79
13.Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N: Schedule for Affective Disorders and Schizophrenia for School-Age Children—Present and Life-time Version (K-SADS-PL: Initial reliability and Validity Data. J Am Acad Child Adoles Psychiatry 1997; 36:980–988
14.Scahill L, Riddle MA, McSwiggin-Hardin M, Ort SI, King RA, Gooman WK, Cicchetti D, Leekman JF: Children’s Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adoles Psychiatry 1997; 36:844–852
15.Leckman JF, Riddle MA, Hardin MT, Ort SL, Swartz KL, Stevenson J, Cohen DJ: The Yale Global Tic Severity Scales initial testing of a clinician rated scale of tic severity. J Am Acad Child Adoles Psychiatry 1989; 28:566–577
16.Mataix-Cols D, Rauch SL, Manzo PA, Jenike MA, Baer L: Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Am J Psychiatry 1999; 156:1409–1416
17.Ammons CH, Ammons RB: The Quick Test (QT): provisional manual. Psychol Rep 1962; 11:111–161
18.Weschler D: Weschler Intelligence Scale for Children, 3rd Ed. San Antonio, Tex, Psychological Corporation, 1991
19.Knights R, Norwood J: Revised Smoothed Normative Data on the Neuropsychological Test Battery for Children. Ottawa, Ontario, Canada, Department of Psychology, Carleton University, 1980
20.Szeszko PR, Bilder RM, Lencz T, Pollack S, Alvir JM, Ashtari M, Wu H, Lieberman JA: Investigation of frontal lobe subregions in first-episode schizophrenia. Psychiatry Res 1999; 90:1–15
21.Tzourrio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M: Neuroimage 2002; 15:273–289
22.Kang DH, Kim JJ, Choi JS, Kim YI, Kim CW, Youn T, Han MH, Chang KH, Kwon JS: Volumetric investigation of the frontal-subcortical circuitry in patients with obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci 2004; 16:342–349
23.Swedo SE, Pietrini P, Leonard HL, Schapiro MB, Rettew DC, Goldberger EL, Rapoport SI, Rapoport JL, Grady CL: Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder: revisualization during pharmacotherapy. Arch Gen Psychiatry 1992; 49:690–694
24.Rauch SL, Shin LM, Dougherty DD, Alpert NM, Fischman AJ, Jenike MA: Predictors of fluvoxamine response in contamination-related obsessive-compulsive disorder: a PET symptom provocation study. Neuropsychopharmacology 2002; 27:782–791
25.Rauch SL, Jenike MA, Alpert NM, Baer L, Breiter HC, Savage CR, Fischman AJ: Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry 1994; 51:62–70
26.Barnett R, Maruff P, Purcell R, Wainwright K, Kyrios M, Brewer W, Pantelis C: Impairment of olfactory identification in obsessive-compulsive disorder. Psychol Med 1999; 29:1227–1233
27.Hurliman E, Nagode JC, Pardo JV: Double dissociation of exteroceptive and interoceptive feedback systems in the orbital and ventromedial prefrontal cortex of humans. J Neurosci 2005; 25:4641–4648
28.Elliott R, Dolan RJ, Frith CD: Dissociable functions in the medial and lateral orbitofrontal cortex: evidence from human neuroimaging studies. Cereb Cortex 2000; 10:308–317
29.Baxter LR, Schwartz JM, Bergman KS, Szuba MP, Guze BH, Mazziotta JC, Alazraki A, Selin CE, Ferng HK, Munford P, Phelps MD: Caudate glucose metabolite changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry 1992; 49:681–689
30.Schmidtke K, Schorb A, Winkelmann G, Hohagen F: Cognitive frontal lobe dysfunction in obsessive-compulsive disorder. Biol Psychiatry 1998; 43:666–673
31.Sanides F: Comparative architectonics of the neocortex of mammals and their evolutionary interpretation. Ann NY Acad Sci 1969; 167:404–423
32.Tucker DM, Luu P, Pribram KH: Social and emotional self-regulation. Ann N Y Acad Sci 1995; 769:213–239
33.Perani D, Colombo C, Bressi S, Bonfanti A, Grassi F, Scarone S, Bellodi L, Smeraldi E, Fazio F: [18F]FDG PET study in obsessive-compulsive disorder: a clinical/metabolic correlation study after treatment. Br J Psychiatry 1995; 166:244–250
34.Rosenberg DR, Keshavan MS, O’Hearn KM, Dick EL, Bagwell WW, Seymour AB, Montrose DM, Pierri JN, Birmaher B: Frontostriatal measurement in treatment-naive children with obsessive-compulsive disorder. Arch Gen Psychiatry 1997; 54:824–830
35.Snider LA, Swedo SE: PANDAS: current status and directions for research. Mol Psychiatry 2004; 9:900–907
36.Rauch SL, Savage CR, Alpert NM, Dougherty D, Kendrick A, Curran T, Brown HD, Manzo P, Fischman AJ, Jenike MA: Probing striatal function in obsessive-compulsive disorder: a PET study of implicit sequence learning. J Neuropsychiatry Clin Neurosci 1997; 9:568–573
37.Rauch SL, Whalen PJ, Savage CR, Curran T, Kendrick A, Brown HD, Bush G, Breiter HC, Rosen BR: Striatal recruitment during an implicit sequence learning task as measured by functional magnetic resonance imaging. Hum Brain Mapp 1997; 5:124–132
38.Kang DH, Kwon JS, Kim JJ, Youn T, Park HJ, Kim MS, Lee DS, Lee MC: Brain glucose metabolic changes associated with neuropsychological improvements after 4 months of treatment in patients with obsessive-compulsive disorder. Acta Psychiatr Scand 2003; 107:291–297
39.Kwon JS, Kim JJ, Lee DW, Lee JS, Lee DS, Kim MS, Lyoo IK, Cho MJ, Lee MC: Neural correlates of clinical symptoms and cognitive dysfunctions in obsessive-compulsive disorder. Psychiatry Res 2003; 122:37–47
40.Breiter HC, Rauch SL, Kwong KK, Baker JR, Weisskoff RM, Kennedy DN, Kendrick AD, Davis TL, Jiang A, Cohen MS, Stern CE, Belliveau JW, Baer L, O’Sullivan RL, Savage CR, Jenike MA, Rosen BR: Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psychiatry 1996; 53:595–606
41.Perani D, Colombo C, Bressi S, Bonfanti A, Grassi F, Scarone S, Bellodi L, Smeraldi E, Fazio F: [18F]FDG PET study in obsessive-compulsive disorder: a clinical/metabolic correlation study after treatment. Br J Psychiatry 1995; 166:244–250
42.Mataix-Cols D, Wooderson S, Lawrence N, Brammer MJ, Speckens A, Phillips ML: Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder. Arch Gen Psychiatry 2004; 61:564–576
43.Szeszko PR, Babak AA, Ashtari M, Malhotra AK, Robinson DG, Bilder RM, Lim KO: White matter abnormalities in obsessive-compulsive disorder: a diffusion tensor imaging study. Arch Gen Psychiatry 2005; 62:782–790